Trial Profile
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel (EDOX-APT): A Prospective Randomized Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Aspirin; Clopidogrel
- Indications Thromboembolism
- Focus Pharmacodynamics
- Acronyms EDOX-APT
- 30 Aug 2019 Results (n=80) published in the Thrombosis and Haemostasis.
- 05 Apr 2018 Status changed from active, no longer recruiting to completed.
- 25 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2018.